605016 Stock Overview

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. More details

605016 fundamental analysis
Snowflake Score
Valuation	5/6
Future Growth	5/6
Past Performance	4/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 46.2% below our estimate of its fair value

Earnings are forecast to grow 30.56% per year

Earnings grew by 34.5% over the past year

Trading at good value compared to peers and industry

Risk Analysis

High level of non-cash earnings

Dividend of 1.03% is not well covered by free cash flows

My Notes

Capture your thoughts, links and company narrative

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Competitors

Shandong Xiantan

SZSE:002746

CN¥5.3b

Shanghai Bolex Food Technology

SHSE:603170

CN¥6.6b

Jiahe Foods Industry

SHSE:605300

CN¥5.4b

Zhongjing Food

SZSE:300908

CN¥4.9b

Price History & Performance

Summary of share price highs, lows and changes for Shandong Bailong Chuangyuan Bio-Tech
Historical stock prices
Current Share Price	CN¥17.85
52 Week High	CN¥23.96
52 Week Low	CN¥14.54
Beta	0.53
1 Month Change	10.66%
3 Month Change	12.69%
1 Year Change	-15.95%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-19.51%

Recent updates

Shareholder Returns

	605016	CN Food	CN Market
7D	6.4%	-3.0%	-1.2%
1Y	-16.0%	4.4%	11.8%

Return vs Industry: 605016 underperformed the CN Food industry which returned 4.4% over the past year.

Return vs Market: 605016 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 605016's price volatile compared to industry and market?
605016 volatility
605016 Average Weekly Movement	7.3%
Food Industry Average Movement	7.3%
Market Average Movement	8.7%
10% most volatile stocks in CN Market	12.8%
10% least volatile stocks in CN Market	5.7%

Stable Share Price: 605016 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 605016's weekly volatility (7%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2005	742	Hongjian Zhuo	www.sdblcy.com

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of functional sugar in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto- oligosaccharide, galacto- oligosaccharide, and xylo- oligosaccharide.

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. Fundamentals Summary

How do Shandong Bailong Chuangyuan Bio-Tech's earnings and revenue compare to its market cap?
605016 fundamental statistics
Market cap	CN¥5.77b
Earnings (TTM)	CN¥234.25m
Revenue (TTM)	CN¥1.03b

24.6x

P/E Ratio

5.6x

P/S Ratio

Is 605016 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
605016 income statement (TTM)
Revenue	CN¥1.03b
Cost of Revenue	CN¥700.55m
Gross Profit	CN¥334.31m
Other Expenses	CN¥100.06m
Earnings	CN¥234.25m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.73
Gross Margin	32.30%
Net Profit Margin	22.64%
Debt/Equity Ratio	4.3%

How did 605016 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

29%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 08:23
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Xia Sheng	Citic Securities Co., Ltd.
Lin Yang	Guosen Securities Co., Ltd.
Wei Liu	Haitong International Research Limited